Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24

1.

Transfusion-transmitted and community-acquired babesiosis in New York, 2004 to 2015.

Linden JV, Prusinski MA, Crowder LA, Tonnetti L, Stramer SL, Kessler DA, White J, Shaz B, Olkowska D.

Transfusion. 2018 Mar;58(3):660-668. doi: 10.1111/trf.14476. Epub 2018 Jan 31.

2.

Creutzfeldt-Jakob disease lookback study: 21 years of surveillance for transfusion transmission risk.

Crowder LA, Schonberger LB, Dodd RY, Steele WR.

Transfusion. 2017 Aug;57(8):1875-1878. doi: 10.1111/trf.14145. Epub 2017 Apr 25.

3.

Standardized Symptom Measurement of Individuals with Early Lyme Disease Over Time.

Bechtold KT, Rebman AW, Crowder LA, Johnson-Greene D, Aucott JN.

Arch Clin Neuropsychol. 2017 Mar 1;32(2):129-141. doi: 10.1093/arclin/acw098.

PMID:
28365751
4.

Prevalence, incidence, and risk factors of human immunodeficiency virus infection in blood donors in the Southeastern United States.

Crowder LA, Steele WR, Notari EP 4th, Hopkins CK, Lima JL, Foster GA, Townsend RL, Krysztof DE, Dodd RY, Stramer SL.

Transfusion. 2017 Feb;57(2):404-411. doi: 10.1111/trf.13891. Epub 2016 Nov 2.

PMID:
27807863
5.

CCL19 as a Chemokine Risk Factor for Posttreatment Lyme Disease Syndrome: a Prospective Clinical Cohort Study.

Aucott JN, Soloski MJ, Rebman AW, Crowder LA, Lahey LJ, Wagner CA, Robinson WH, Bechtold KT.

Clin Vaccine Immunol. 2016 Sep 6;23(9):757-66. doi: 10.1128/CVI.00071-16. Print 2016 Sep.

6.

Lyme disease and post-treatment Lyme disease syndrome: the neglected disease in our own backyard.

Crowder LA, Yedlin VA, Weinstein ER, Kortte KB, Aucott JN.

Public Health. 2014 Sep;128(9):784-91. doi: 10.1016/j.puhe.2014.06.016. Epub 2014 Sep 9.

PMID:
25213101
7.

Characteristics of seroconversion and implications for diagnosis of post-treatment Lyme disease syndrome: acute and convalescent serology among a prospective cohort of early Lyme disease patients.

Rebman AW, Crowder LA, Kirkpatrick A, Aucott JN.

Clin Rheumatol. 2015 Mar;34(3):585-9. doi: 10.1007/s10067-014-2706-z. Epub 2014 Jun 13.

PMID:
24924604
8.

Serum inflammatory mediators as markers of human Lyme disease activity.

Soloski MJ, Crowder LA, Lahey LJ, Wagner CA, Robinson WH, Aucott JN.

PLoS One. 2014 Apr 16;9(4):e93243. doi: 10.1371/journal.pone.0093243. eCollection 2014.

9.

Development of a foundation for a case definition of post-treatment Lyme disease syndrome.

Aucott JN, Crowder LA, Kortte KB.

Int J Infect Dis. 2013 Jun;17(6):e443-9. doi: 10.1016/j.ijid.2013.01.008. Epub 2013 Feb 23.

10.

Bull's-Eye and Nontarget Skin Lesions of Lyme Disease: An Internet Survey of Identification of Erythema Migrans.

Aucott JN, Crowder LA, Yedlin V, Kortte KB.

Dermatol Res Pract. 2012;2012:451727. doi: 10.1155/2012/451727. Epub 2012 Oct 24.

11.

Post-treatment Lyme disease syndrome symptomatology and the impact on life functioning: is there something here?

Aucott JN, Rebman AW, Crowder LA, Kortte KB.

Qual Life Res. 2013 Feb;22(1):75-84.

12.

Dopamine acutely stimulates Na+/H+ exchanger (NHE3) endocytosis via clathrin-coated vesicles: dependence on protein kinase A-mediated NHE3 phosphorylation.

Hu MC, Fan L, Crowder LA, Karim-Jimenez Z, Murer H, Moe OW.

J Biol Chem. 2001 Jul 20;276(29):26906-15. Epub 2001 Apr 27.

13.

Dual mechanisms of regulation of Na/H exchanger NHE-3 by parathyroid hormone in rat kidney.

Fan L, Wiederkehr MR, Collazo R, Wang H, Crowder LA, Moe OW.

J Biol Chem. 1999 Apr 16;274(16):11289-95.

14.

Acute inhibition of Na/H exchanger NHE-3 by cAMP. Role of protein kinase a and NHE-3 phosphoserines 552 and 605.

Zhao H, Wiederkehr MR, Fan L, Collazo RL, Crowder LA, Moe OW.

J Biol Chem. 1999 Feb 12;274(7):3978-87.

15.

Behavioral effects of methyl parathion and toxaphene exposure in rats.

Crowder LA, Lanzaro GC, Whitson RS.

J Environ Sci Health B. 1980;15(4):365-78.

PMID:
7400539
16.
17.
18.

Uptake of 36CL-toxaphene in the cockroach, Leucophaea maderae (Fabr.).

Dary CC, Crowder LA.

Bull Environ Contam Toxicol. 1977 Dec;18(6):766-72. No abstract available.

PMID:
597631
19.

Uptake of 36Cl-toxaphene in mosquito fish, Gambusia affinis.

Schaper RA, Crowder LA.

Bull Environ Contam Toxicol. 1976 May;15(5):581-7.

PMID:
946771
20.

Fatty acids of diapause and nondiapause pink bollworm larvae, Pectinophora Gossypiella (Saunders).

Foster DR, Crowder LA.

Comp Biochem Physiol B. 1976;55(4):519-21. No abstract available.

PMID:
1000942
21.

Fate of 36C1-toxaphene in rats.

Crowder LA, Dindal EF.

Bull Environ Contam Toxicol. 1974 Sep;12(3):320-7. No abstract available.

PMID:
4433877
22.

Effects of a juvenile hormone mimic on the pink bollworm.

Cawich A, Crowder LA, Watson TF.

J Econ Entomol. 1974 Apr;67(2):173-6. No abstract available.

PMID:
4833473
23.

Binding of 36C1-dieldrin to suspected target and non-target proteins in vitro.

Jakubowski T, Crowder LA.

Bull Environ Contam Toxicol. 1973 Oct;10(4):217-24. No abstract available.

PMID:
4755259
24.

Leiobunum longipes: radioautographic localization of 5-hydroxytryptamine.

Crowder LA, Goodnight CJ.

Trans Am Microsc Soc. 1970 Jul;89(3):375-83. No abstract available.

PMID:
5483253

Supplemental Content

Loading ...
Support Center